• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Bluebird Bio Inc

+ Add to Watchlist

BLE1:GR

25.306 EUR 0.716 2.75%

As of 02:05:13 ET on 07/23/2014.

Snapshot for Bluebird Bio Inc (BLE1)

Open: 25.125 Day's Range: 25.125 - 25.306 Volume: 0
Previous Close: 26.022 52wk Range: 12.510 - 32.000 1-Yr Rtn: +2.28%

Stock Chart for BLE1

No chart data available.
  • BLE1:GR 25.306
  • 1D
  • 1M
  • 1Y
26.022
Interactive BLE1 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BLE1

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -1.7750
Est. PEG Ratio -
Market Cap (M EUR) 697.18
Shares Outstanding (M) 27.55
30 Day Average Volume 123
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/13/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BLE1

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for BLE1

Bluebird Bio, Inc. provides biotechnological products and services. The Company offers gene therapies for severe genetic disorders such as childhood cerebral adrenoleukodystrophy, neurodegenerative disorders, and beta-thalassemia. Bluebird Bio conducts its business in the United States.

Daniel S Lynch "Dan"ChairmanNick LeschlyPresident/CEO
Jeffrey T Walsh "Jeff"COO/TreasurerDavid M DavidsonChief Medical Officer
More Company Profile & Key Executives for BLE1

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil